Monsanto rejects Bayer’s revised financial offer

Monsanto has announced that its Board of Directors unanimously views Bayer AG’s revised proposal as financially inadequate and insufficient to ensure deal certainty.
By ICN Bureau
Chemical, July 20 , 2016

Monsanto has announced that its Board of Directors unanimously views Bayer AG’s revised proposal as financially inadequate and insufficient to ensure deal certainty.

Monsanto remains open to continued and constructive conversations with Bayer and other parties to assess whether a transaction that the Board believes is in the best interest of Monsanto shareowners can be realized. There is no assurance that any transaction will be entered into or consummated, or on what terms.

Morgan Stanley & Co. and Ducera Partners are acting as final.


Other Chemical

November 22 , 2017

Net sales reported at Rs. 244.89 crores for the quarter ending September 30, 2017, as against Rs. 21

November 22 , 2017

Brexit without a new trade agreement between the UK and the EU would be the worst possible outcome

November 21 , 2017

Net sales reported at Rs. 418.92 crores for the quarter ending September 30, 2017, as against Rs. 44

View All